Literature DB >> 22866106

Comparison of protein profiles between acetonitrile- and non-acetonitrile-treated sera from patients with nasopharyngeal carcinomas.

Yuan-Jiao Huang1, Kai-Feng Deng, Chao Xuan, Bei-Bei Zhang, Yi Zhou, Xiaoli Yang, Ming He.   

Abstract

Serum proteins may be abnormally increased or decreased during the occurrence and development of nasopharyngeal carcinoma (NPC). However, currently there are no simple or effective methods to collect and differentiate these abnormally secreted proteins from abundant serum proteins. In this study, acetonitrile was used to remove the majority of high-abundance proteins from serum samples obtained from patients with NPC. The samples were subjected to surface-enhanced laser desorption/ionization time-of-flight mass spectrometry with a CM10 (weak cation exchange) ProteinChip, and the resulting protein profiles were compared with those of non-acetonitrile-treated serum samples. The results showed that the protein profiles differed between the acetonitrile- and non-acetonitrile-treated sera from patients with NPC. A large proportion of the non-acetonitrile-treated NPC serum protein peaks were <6000 kDa, while the detection rate of protein peaks >6000 kDa was relatively higher in the acetonitrile-treated NPC sera, accounting for more than half of all protein peaks (26.2+37.5%). Few differentially upregulated proteins were lost, and the peak value density increased after acetonitrile treatment. In conclusion, acetonitrile treatment of serum samples is effective in removing high-abundance macromolecular proteins. Therefore, acetonitrile treatment can be applied for the investigation of serum proteomics and may aid in the identification of differentially expressed proteins.

Entities:  

Year:  2011        PMID: 22866106      PMCID: PMC3410449          DOI: 10.3892/ol.2011.284

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  7 in total

1.  Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry.

Authors:  Joshua N Adkins; Susan M Varnum; Kenneth J Auberry; Ronald J Moore; Nicolas H Angell; Richard D Smith; David L Springer; Joel G Pounds
Journal:  Mol Cell Proteomics       Date:  2002-12       Impact factor: 5.911

2.  Tricine-SDS-PAGE.

Authors:  Hermann Schägger
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.

Authors:  Patrick C Ma; Lawrence Blaszkowsky; Ajit Bharti; Andras Ladanyi; Stine-Kathrein Kraeft; Adam Bruno; Arthur T Skarin; Lan Bo Chen; Ravi Salgia
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

4.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

5.  Efficient and specific removal of albumin from human serum samples.

Authors:  Laura F Steel; Michael G Trotter; Pamela B Nakajima; Taj S Mattu; Gregory Gonye; Timothy Block
Journal:  Mol Cell Proteomics       Date:  2003-05-16       Impact factor: 5.911

6.  Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry.

Authors:  Oleg Chertov; Arya Biragyn; Larry W Kwak; John T Simpson; Tatiana Boronina; Van M Hoang; DaRue A Prieto; Thomas P Conrads; Timothy D Veenstra; Robert J Fisher
Journal:  Proteomics       Date:  2004-04       Impact factor: 3.984

7.  SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma.

Authors:  Yuan-Jiao Huang; Chao Xuan; Bei-Bei Zhang; Ming Liao; Kai-Feng Deng; Min He; Jin-Min Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.